Corporate Finance

An Atlanta clinic's top award highlights a market shift toward minimally invasive fibroid treatment and a crucial fight for health equity in women's care.

Junior miner Walker Lane Resources seeks a strategic partner after permitting woes stalled its 2025 plans. Can it unlock its Nevada gold potential?

With a new M&A-savvy CRO and Blackstone's backing, Enverus is poised for aggressive growth, aiming to dominate the AI-driven future of energy intelligence.

A routine UK regulatory filing from hedge fund Kite Lake Capital exposes a calculated short position on Qualcomm, hinting at a hidden M&A drama.

BayWa r.e.'s new solar and storage park is more than infrastructure; it's a blueprint for financing, grid stability, and navigating complex community politics.

A routine dividend from Imperial Petroleum reveals a powerful strategy: a debt-free balance sheet and cash-funded growth in a volatile shipping market.

A massive breach at fintech pioneer Prosper exposes 17.6M users' SSNs and bank data, sparking a crisis of trust and security questions for the industry.

A routine regulatory filing reveals First Trust's 4.99% stake in NCC Group, fueling speculation around the struggling cybersecurity firm's future.

An Australian biotech's novel gel delivery system aims to conquer China's wellness market. But can superior tech alone build the trust needed to succeed?

A key advisory appointment reveals a pivotal trend in private equity: a move from deal-making to deep operational focus for maximizing portfolio returns.

NMI launches Business Capital, an embedded lending tool giving healthcare providers fast access to funds. Is this the lifeline the industry needs?

J.P. Morgan's 2026 outlook reveals how private markets, fueled by AI, are rebuilding the physical backbone of the global supply chain.

A new star-studded series celebrates Shenzhen's rise. Beyond the screen, it reveals a carefully crafted blueprint for national branding and economic ambition.

Stunning trial data reveals an immunotherapy combo that slashes myeloma progression by 83%, offering not just longer life but a better quality of life.

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?

Domestic manufacturing, massive power demands from AI and EVs, and a skilled labor shortage are converging to define a pivotal year for American industry.

With a $12M boost from a16z, Pryzm's AI is tackling the Pentagon's $900B procurement problem. Can software fix bureaucracy and secure America's edge?

A new partnership moves elite market data from raw feeds to interactive widgets, aiming to reshape advisor workflows and intensify WealthTech competition.

HPP's routine preferred stock payout seems minor, but it reveals a deeper story of financial health and a strategic bet on a tech and media rebound.

An Austin firm’s massive growth to $30B AUM reveals a key trend: specialized asset managers are becoming the new architects of our connected future.